跳到主要內容

癌症治療相關的皮膚病灶 skin lesions related to therapies of cancers

 癌症治療相關的皮膚病灶 skin lesions related to therapies of cancers


名稱

表徵

說明

hand-foot syndrome(圖一)

最初症狀,化療後第一天,但可以在數次化療後出現:tingling, numbness, tightness, stiffness or pain in the palms/fingers and sometimes a little later also the soles of feet/toes

初始症狀出現後2-4天:

symmetric erythema and edema in palms and soles, accompanied by onset of neuropathic pain, which can progress to blistering with desquamation, erosion, and ulceration

手掌>足底、常見於受壓處

Pegylated liposomal doxorubicin(常見)capecitabine5-fluorouracil(最常見)cytarabinedocetaxeldoxorubicin相關,停止化療可以有效解決此問題,化療前使用用保濕液moisturizers [ˈmɔɪstʃəˌraɪzɚ]對此有幫助,並避免傷害(熱、物理性、壓力、刺激性物質),若已發生,可用冰敷、止痛、抬高患處,嘗試使用topical or oral steroidtopical and oral pyridoxine (vitamin B6)

hand-foot skin reaction,圖片如下

https://reurl.cc/9rz2an

 

Localized, tender lesions over areas subjected to friction or trauma, which may appear as blisters or focal hyperkeratosis overlying an erythematous base and affects flexural and pressure-bearing areas, including fingertips, interdigital web spaces, heels, lateral aspect of feet, and over joints

疼痛、感覺異常(paresthesia)、刺痛、痠痛,熱忍受力下降

足底>手掌、常見於受壓處

出現在使用tyrosine kinase inhibitors 2-4週後,Multikinase inhibitors也可以出現 (sorafenib, sunitinib, axitinib, pazopanib, regorafenib, bevacizumab, and vemurafenib),可用urea藥膏於角質化處,並保持濕潤、避免摩擦,若有疼痛問題可使用lidocaine gel,嚴重者可使用topical steroid,有傷口處使用topical antibiotics

flagellate erythema
(flagellate dermatitis)(
圖二)

pruritic, erythematous, linear streaks that resemble whiplash(鞭打,  [ˈwɪpˌlæʃ] marks, hence the name flagellate (鞭打, [ˈflædʒəˌlet]),搔癢的症狀可能早於皮膚徵象

原因包含bleomycinpeplomycindocetaxel、皮肌炎dermatomyositis、成人史迪爾氏症候群adult-onset Still disease、香菇皮膚炎Shiitake mushroom dermatitis (吃生香菇而產生,與lentinan相關),會自行緩解,可使用oral antihistamines,topical steroidsystemic steroid、冰敷處理,注意熱源可能導致復發(heat-induced recall)、避免曬太陽。

PRIDE

l   Papulopustules and/or paronychia

l   Regulatory abnormalities of hair growth

l   Itching

l   Dryness

l   due to Epidermal growth factor receptor inhibitors

以上是和EGFR inhibitors相關。

Papulopustules

影響45-100%的病人,常發生在臉及上半身。可用clindamyicn gel, tetracycline PO, doxycycline PO, minocycline PO來調解免疫反應,若依然有嚴重的頭皮病灶,可用rinderon (topical steroid做治療),有時候會伴隨S. aureus感染,可用dicloxacillin 1# 250mg拆開來泡250 ml 生理食鹽水,浸濕紗布敷在頭頂、臉上(wet compression),時間不限,若是效果有限,可用levofloxacin 1#並搭配以上方法處理,使用一週後換回dicloxacillin

甲溝炎Paronychia [ˌpærəˈnɪkiə]

影響45-100%的病人,會有強烈的疼痛(exquisite tenderness),可能合併甲床剝離(onycholysis, [ˌɑnɪˈkɑlɪsɪs])、指甲萎縮(onychodystrophy),可用doxycyclinehigh-potency topical corticosteroidtopical calcineurin inhibitor tacrolimus做治療。

Regulatory abnormalities of hair growth, eg. nonscarring alopecia [ˌæləˈpiʃə], 睫毛粗長症trichomegaly of the eyebrows, increased hair in the face, 鼻孔nares /ˈəriz/ and eyelashes

睫毛部分可會診眼科處理。

Drynessxerosis \ zi-ˈrō-səs \乾燥症

影響7-35%的病人,常發生於紅疹處,用保濕液moisturizers [ˈmɔɪstʃəˌraɪzɚ]和潤膚劑emollients [ɪˈmɑljənt]處理,若導致搔癢的情形,可搭配抗組織胺antihistamines [ˌæntiˈhɪstəˌmin]來控制症狀。


(圖一) Hand-foot syndrome,資料來源:https://dermnetnz.org/topics/hand-foot-syndrome/

 


(圖二) flagellate erythema,資料來源:https://dermnetnz.org/topics/shiitake-flagellate-dermatitis/

資料來源

l   Lacouture, M. E., & Lai, S. E. (2006). The PRIDE (Papulopustules and/or paronychia, Regulatory abnormalities of hair growth, Itching, and Dryness due to Epidermal growth factor receptor inhibitors) syndrome. British Journal of Dermatology, 155(4), 852-854.

l   https://dermnetnz.org/topics/flagellate-erythema/

l   https://www.uptodate.com/contents/cutaneous-side-effects-of-conventional-chemotherapy-agents?search=flagellate%20dermatitis&source=search_result&selectedTitle=3~22&usage_type=default&display_rank=3

l   https://www.uptodate.com/contents/hand-foot-skin-reaction-induced-by-multitargeted-tyrosine-kinase-inhibitors?search=hand%20foot%20skin%20reaction&source=search_result&selectedTitle=1~28&usage_type=default&display_rank=1#H779678639

l   Miller, K. K., Gorcey, L., & McLellan, B. N. (2014). Chemotherapy-induced hand-foot syndrome and nail changes: a review of clinical presentation, etiology, pathogenesis, and management. Journal of the American Academy of Dermatology, 71(4), 787-794.

l   Lu, C. W., Wu, C. E., Hsu, P. C., Fang, Y. F., Li, S. H., Tseng, L. C., & Shih, F. Y. (2021). Topical dicloxacillin solution wash for papulopustular eruptions and purpuric drug eruptions due to epidermal growth factor inhibitors. International journal of dermatology.

留言

這個網誌中的熱門文章

2021慢性正常收縮分率心衰竭的治療 Management of Chronic HFpEF of ESC Guideline in 2021

2021 慢性 正常收縮分率心衰竭 的治療   Management of Chronic Heart failure with Preserved Ejection Fraction of ESC Guideline in 2021 l    診斷: 症狀 ± 徵象、 LVEF ≥ 50% 、客觀證據顯示符合 LV 舒張異常、 LV filling pressures 上升的心臟結構或功能異常 ( 包含 NPs 上升 ) ,所謂客觀證據參考下表 參數 門檻 備註 LV mass index Relative wall thickness 女: ≥ 95 g/m 2 ;男: ≥ 115 g/m 2 > 0.42 若有出現同心 (concentric) LV remodeling 或 LVH 會支持此診斷,但沒有無法排除 HFpEF   LA volume index >34 mL/m 2 (SR) >40 mL/m 2 (AF) 在沒有 AF 和瓣膜疾病的情況下, LA enlargement 反應慢性 LV filling pressure 過高 E/e’ ratio at rest >9 利用 invasive exercise testing 診斷 HFpEF 的 sensitivity 78% 、 specificity 59% ;若設定為 >13 , sensitivity 46% 、 specificity 86% NT-proBNP BNP >125 (SR) 或 >365 (AF) pg/mL >35 (SR) 或 >105 (AF) pg/mL 在用侵入性檢查證實 HFpEF 的病人中, 高達 20% 的病人 NPs 低於診斷門檻 ,特別是肥胖的病人 PA systolic pressure TR velocity a

目錄

目錄   l    文書相關 n    病例寫作常用句子及應注意文句 l    臨床操作 n    子宮頸抹片 pap smears 及內診 per vaginal examination (OSCE 攻略 ) n    乳房腫塊 breast mass 與乳 房觸診 breast palpation (OSCE 攻略 ) n    鼻胃管置入 nasogastric tube insertion (OSCE 攻略 ) n    肛門指診 digital rectal examination (OSCE 攻略 ) n    靜脈留置針置入術 intravenous catheter insertion (OSCE 攻略 ) n    經口氣管插管 endotracheal Intubation (OSCE 攻略 ) n    拔除 JP 引流管 removal of Jackson-Pratt drain n    換氣切管 change tracheostomy inner tube n    如何移除硬脊膜外自控式止痛 How to remove patient-controlled epidural analgesia n    人工血管不順該怎麼處理 n    動脈導管置放 arterial line placement l    感染科 n    痰液培養 sputum culture n    抗生素的劑量調整 n    無症狀菌尿症之處置 (2019 年更新之 IDSA 臨床指引 ) Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the IDSA l    心臟內科 n    重症病人新發心房纖維性顫動之處理 management of new-onset atrial fibrillation during critical illness n    心肌梗塞之診斷 diagnosis of acute myocardial infarction n    HEART 風險評分 n    TIMI

咳血之檢查及處置survey and management of hemoptysis

  咳血之檢查及處置    survey and management of hemoptysis l    病因 呼吸道 支氣管炎 支氣管擴張 癌症 肺血管廔管 異物 支氣管結石 肺實質 肺膿瘍 肺結核 細菌感染 鉤端螺旋體病 Leptospirosis 寄生蟲 ( 例如 Paragonimus westermani, Strongyloides) 病毒感染 Goodpasture disease Behçet disease 血管炎 紅斑性狼瘡 (SLE) 子宮內膜異位症   心血管疾病 心臟衰竭 二尖瓣狹窄 肺栓塞 Pulmonary artery pseudoaneurysm 肺部動靜脈畸型 Pulmonary arteriovenous malformation Pulmonary and bronchial artery aneurysms 肺靜脈閉塞病 Pulmonary veno-occlusive disease     出血問題或創傷 服用抗凝血劑 泛發性血管內血液凝固症 (DIC) 血小板功能障礙 血小板低下 Von Willebrand disease   挫傷或穿刺傷 呼吸道支架 氣管氣球擴張術 切片 氣管插管侵